Literature DB >> 25907629

Virulency of novel nanolarvicide from Trichoderma atroviride against Aedes aegypti (Linn.): a CLSM analysis.

Gavendra Singh1, Soam Prakash.   

Abstract

Aedes aegypti is the vector for transmitting dengue, chikungunya, and yellow fever. These diseases' transmission has increased predominantly in urban and semi-urban areas as a major public health concern. In present investigation, Trichoderma atroviride culture filtrates were used for the synthesis of silver nanoparticle. Moreover, T. atroviride is a free-living and rapidly growing fungi common in soil and root ecosystem. This fungi is an exceptionally good model for biocontrol and more significant as a bioagent. T. atroviride was grown in malt extract. T. atroviride culture filtrates were exposed to silver nitrates solution for 24 h at 25 °C for the synthesis of silver nanoparticles (AgNPs). These AgNPs were characterized to find their unique properties with UV-visible spectrophotometer and transmission electron microscope (TEM) analysis. The T. atroviride culture filtrates have formed hexagonal (diamond shape) AgNPs with the range of size of 14.01-21.02 nm. These AgNPs have shown significant efficacies against first, second, third, and fourth instar larvae of A. aegypti. The LC90 and LC99 values for the first instar were 1 and 3 ppm, second instar 2 and 3.18 ppm, third instar 3.12 and 4.12 ppm, and fourth instar 6.30 and 6.59 ppm, respectively, after an exposure of 7 h. The confocal laser scanning microscopy (CLSM) studies were verdict that these AgNPs embedded in the cuticle of larvae and cause instant lethality in 7 h. Present investigations have demonstrated that the AgNPs of T. atroviride culture filtrates synthesized can be used for larvae control of A. aegypti. T. atroviride is synthesized to silver nanoparticles to be a promising new candidate for application in mosquito control. We therefore suggested that the ability of T. atroviride culture filtrates in synthesis can also be explored for synthesizing silver nanoparticles for commercial exploitation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25907629     DOI: 10.1007/s11356-015-4531-6

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  25 in total

1.  Ecology: A world without mosquitoes.

Authors:  Janet Fang
Journal:  Nature       Date:  2010-07-22       Impact factor: 49.962

2.  Biosynthesized silver nanoparticles from Pedilanthus tithymaloides leaf extract with anti-developmental activity against larval instars of Aedes aegypti L. (Diptera; Culicidae).

Authors:  Chandran Sundaravadivelan; Madanagopal Nalini Padmanabhan; Prabhu Sivaprasath; Lingan Kishmu
Journal:  Parasitol Res       Date:  2012-09-30       Impact factor: 2.289

3.  Larvicidal activity of synthesized silver nanoparticles using Eclipta prostrata leaf extract against filariasis and malaria vectors.

Authors:  G Rajakumar; A Abdul Rahuman
Journal:  Acta Trop       Date:  2011-03-17       Impact factor: 3.112

4.  Larvicidal potential of silver nanoparticles synthesized using fungus Cochliobolus lunatus against Aedes aegypti (Linnaeus, 1762) and Anopheles stephensi Liston (Diptera; Culicidae).

Authors:  Rahul B Salunkhe; Satish V Patil; Chandrashekhar D Patil; Bipinchandra K Salunke
Journal:  Parasitol Res       Date:  2011-03-31       Impact factor: 2.289

5.  Synthesis of eco-friendly silver nanoparticles from Morinda tinctoria leaf extract and its larvicidal activity against Culex quinquefasciatus.

Authors:  K Ramesh Kumar; N Nattuthurai; Ponraj Gopinath; Tirupathi Mariappan
Journal:  Parasitol Res       Date:  2014-11-07       Impact factor: 2.289

6.  Mosquito larvicidal properties of silver nanoparticles synthesized using Heliotropium indicum (Boraginaceae) against Aedes aegypti, Anopheles stephensi, and Culex quinquefasciatus (Diptera: Culicidae).

Authors:  Kaliyan Veerakumar; Marimuthu Govindarajan; Mohan Rajeswary; Udaiyan Muthukumaran
Journal:  Parasitol Res       Date:  2014-04-26       Impact factor: 2.289

7.  Biolarvicidal and pupicidal potential of silver nanoparticles synthesized using Euphorbia hirta against Anopheles stephensi Liston (Diptera: Culicidae).

Authors:  Karthikeyan Agalya Priyadarshini; Kadarkarai Murugan; Chellasamy Panneerselvam; Sekar Ponarulselvam; Jiang-Shiou Hwang; Marcello Nicoletti
Journal:  Parasitol Res       Date:  2012-05-06       Impact factor: 2.289

8.  Evaluation of plant-mediated synthesized silver nanoparticles against vector mosquitoes.

Authors:  Kaliyan Veerakumar; Marimuthu Govindarajan; S L Hoti
Journal:  Parasitol Res       Date:  2014-10-10       Impact factor: 2.289

9.  Low-cost and eco-friendly green synthesis of silver nanoparticles using Feronia elephantum (Rutaceae) against Culex quinquefasciatus, Anopheles stephensi, and Aedes aegypti (Diptera: Culicidae).

Authors:  Kaliyan Veerakumar; Marimuthu Govindarajan; Mohan Rajeswary; Udaiyan Muthukumaran
Journal:  Parasitol Res       Date:  2014-03-20       Impact factor: 2.289

10.  How to make evolution-proof insecticides for malaria control.

Authors:  Andrew F Read; Penelope A Lynch; Matthew B Thomas
Journal:  PLoS Biol       Date:  2009-04-07       Impact factor: 8.029

View more
  3 in total

Review 1.  A scoping review of published literature on chikungunya virus.

Authors:  Mariola Mascarenhas; Sophiya Garasia; Philippe Berthiaume; Tricia Corrin; Judy Greig; Victoria Ng; Ian Young; Lisa Waddell
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

Review 2.  Innovative Preventive and Resilience Approaches Against Aedes-linked Vector-borne Arboviral Diseases Threat and Epidemics Burden in Gulf Council Countries.

Authors:  Ernest Tambo; Ashraf G El Dessouky; Emad I M Khater
Journal:  Oman Med J       Date:  2019-09

Review 3.  Green Nano-Biotechnology: A New Sustainable Paradigm to Control Dengue Infection.

Authors:  Tanzeel Zohra; Ali Talha Khalil; Faryal Saeed; Bushra Latif; Muhammad Salman; Aamer Ikram; Muhammad Ayaz; H C Ananda Murthy
Journal:  Bioinorg Chem Appl       Date:  2022-08-08       Impact factor: 4.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.